MedTrace Logo

Progesterone Levels and Pregnancy Results

NCT04400149 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-11-02

No results posted yet for this study

Summary

The aim of this study is to evaluate the amniotic fluid and serum progesterone level and pregnancy outcome

Conditions

  • Pregnancy Complications
  • Pregnancy Preterm
  • Pregnancy Loss

Interventions

DIAGNOSTIC_TEST

amniocentesis

amniocentesis will be performed to the pregnant women at 16-20 weeks who had a high-risk antenatal test. Furthermore, these women also give a blood sample (at 16-20 weeks) to compare the amniotic fluid and serum progesterone levels in association with pregnancy outcomes. We perform amniocentesis to evaluate genetic disorders in pregnant women who had his risk in the antenal test.

Sponsors & Collaborators

  • Ufuk University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-06-20
Completion
2022-11-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04400149 on ClinicalTrials.gov